ALAB250117P165000
- 39.00
- 0.000.00%
Astera Labs Newsroom
Astera Labs Price Target Maintained With a $142.00/Share by Morgan Stanley
Astera Labs Cut to Equal-Weight From Overweight by Morgan Stanley
Morgan Stanley Downgrades Astera Labs(ALAB.US) to Hold Rating, Maintains Target Price $142
Astera Labs: Hold Rating Maintained Amid High Valuation and Competitive Risks
Astera Labs Is Maintained at Overweight by Barclays
Astera Labs Analyst Ratings
Barclays Maintains Astera Labs(ALAB.US) With Buy Rating, Raises Target Price to $135
Stifel Maintains Astera Labs(ALAB.US) With Buy Rating, Raises Target Price to $150
Astera Labs Is Maintained at Buy by Stifel
Astera Labs Analyst Ratings
Astera Labs Price Target Raised to $120.00/Share From $100.00 by Northland Capital Markets
Northland Downgrades Astera Labs to Market Perform From Outperform, Price Target Is $120
Morgan Stanley raised the Target Price for Astera Labs to $142.
Morgan Stanley Maintains Astera Labs(ALAB.US) With Buy Rating, Raises Target Price to $142
Morgan Stanley Reaffirms Their Buy Rating on Astera Labs, Inc. (ALAB)
Astera Labs Analyst Ratings
Morgan Stanley Boosts Price Target on Astera Labs to $142 From $94, Keeps Overweight Rating
Barclays Sticks to Its Buy Rating for Astera Labs, Inc. (ALAB)
Roth MKM Maintains Astera Labs(ALAB.US) With Buy Rating, Raises Target Price to $130
Analysts' Top NA Picks: Ibotta, Inc. Class A (IBTA), Astera Labs, Inc. (ALAB)